Ketamine may exert antidepressant effects via mediating the kynurenine pathway

Author： Yang Chun Zhou Zhiqiang Shi Jinyun Yang Jianjun

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.12, 2011-12, pp. : 1423-1424

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of the kynurenine pathway

By Stone T.W.

European Journal of Medicinal Chemistry, Vol. 35, Iss. 2, 2000-02 ,pp. : 179-186

Elsevier

Access to resources Recommend Favorite

Kynurenine Pathway and Disease: An Overview

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 6, 2007-12 ,pp. : 398-410

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR

By Akinfiresoye Luli Tizabi Yousef

Psychopharmacology, Vol. 230, Iss. 2, 2013-11 ,pp. : 291-298

Springer Publishing Company

Access to resources Recommend Favorite

In vivo evidence that l-S-nitrosocysteine may exert its vasodilator effects by interaction with thiol residues in the vasculature

By Hoque A. Bates J.N. Lewis S.J.

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

The use of ketamine as an antidepressant: a systematic review and meta‐analysis

Human Psychopharmacology: Clinical And Experimental (Electronic), Vol. 30, Iss. 3, 2015-05 ,pp. : 152-163

John Wiley & Sons Inc

Access to resources Recommend Favorite